Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of oral ABP-745 in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• ABP-745

Snippet

Sponsor: Atom Therapeutics Co., Ltd | Conditions: Gout, Acute Gout Flare | Phase 1 | Status: COMPLETED